The compound was tested on human multiple myeloma (MM) U266 cells and caused pro-apoptotic effects through ROS-mediated activation of ERK, JNK, and p38 MAPK pathways and the activation of caspase-3 in the cells (Baek et al. Here, CASP3 is linked to plasma cell myeloma.